{"id":435962,"date":"2026-03-02T08:45:56","date_gmt":"2026-03-02T08:45:56","guid":{"rendered":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/?p=435962"},"modified":"2026-04-24T13:14:00","modified_gmt":"2026-04-24T13:14:00","slug":"why-longevity-might-be-biopharmas-next-big-thing","status":"publish","type":"post","link":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/blog\/why-longevity-might-be-biopharmas-next-big-thing\/","title":{"rendered":"\u4e3a\u4f55\u957f\u5bff\u7814\u7a76\u53ef\u80fd\u6210\u4e3a\u751f\u7269\u5236\u836f\u7684\u4e0b\u4e00\u4e2a\u98ce\u53e3\uff1a\u5f53\u79d1\u5b66\u4e0e\u5546\u4e1a\u7684\u4ea4\u6c47"},"content":{"rendered":"<p>\u957f\u5bff\u7814\u7a76\u66fe\u88ab\u8ba4\u4e3a\u662f\u672a\u6765\u4e3b\u4e49\u8005\u548c\u8fb9\u7f18\u79d1\u5b66\u5bb6\u7684\u9886\u57df\uff0c\u73b0\u5df2\u8fc5\u901f\u6210\u4e3a\u836f\u7269\u5f00\u53d1\u4e2d\u6700\u5f15\u4eba\u6ce8\u76ee\u7684\u524d\u6cbf\u4e4b\u4e00\u3002\u8fd9\u4e00\u8f6c\u53d8\u5e76\u975e\u4e00\u8e74\u800c\u5c31\uff0c\u81ea 2024 \u5e74\u4ee5\u6765\uff0c\u79d1\u5b66\u7a81\u7834\u3001\u76d1\u7ba1\u6f14\u53d8\u548c\u524d\u6240\u672a\u6709\u7684\u5546\u4e1a\u5229\u76ca\u5171\u540c\u63a8\u52a8\u8870\u8001\u751f\u7269\u5b66\u4ece\u5b66\u672f\u5174\u8da3\u8d70\u5411\u4e86\u4f01\u4e1a\u6218\u7565\u3002<\/p>\n<p>\u6570\u636e\u63ed\u793a\u4e86\u90e8\u5206\u4e8b\u5b9e\uff1a\u4ec5\u5728 2024 \u5e74\uff0c\u4e13\u6ce8\u4e8e\u957f\u5bff\u7814\u7a76\u7684\u521d\u521b\u516c\u53f8\u5c31\u5438\u5f15\u4e86 85 \u4ebf\u7f8e\u5143\u7684\u98ce\u9669\u6295\u8d44\uff0c\u662f\u524d\u4e00\u5e74\u4f4e\u8ff7\u65f6\u671f\u7684\u4e24\u500d\u591a\u3002\u9884\u8ba1\u5230 2030 \u5e74\uff0c\u66f4\u5e7f\u6cdb\u7684\u957f\u5bff\u5e02\u573a\u5c06\u4ece 2023 \u5e74\u7684 5.3 \u4e07\u4ebf\u7f8e\u5143\u589e\u957f\u5230 8 \u4e07\u4ebf\u7f8e\u5143\u3002\u7136\u800c\uff0c\u8f83\u4e4b\u8d44\u91d1\u6d8c\u5165\uff0c\u66f4\u5177\u6839\u672c\u6027\u7684\u53d8\u5316\u5728\u4e8e\u5927\u578b\u5236\u836f\u516c\u53f8\u4e0d\u518d\u5bf9\u8870\u8001\u751f\u7269\u5b66\u6301\u89c2\u671b\u6001\u5ea6\uff0c\u800c\u662f\u5f00\u59cb\u56f4\u7ed5\u8870\u8001\u751f\u7269\u5b66\u6210\u7acb\u4e13\u95e8\u90e8\u95e8\u3002<\/p>\n<h3><strong>GLP-1 \u7684\u542f\u793a\uff1a\u8870\u8001\u751f\u7269\u5b66\u8d70\u5411\u4e3b\u6d41<\/strong><\/h3>\n<p>\u5728\u8bf8\u591a\u63a8\u52a8\u56e0\u7d20\u4e2d\uff0cGLP\u20111 \u53d7\u4f53\u6fc0\u52a8\u5242\u7684\u5feb\u901f\u8d70\u7ea2\u5c24\u4e3a\u5173\u952e\u3002\u8bfa\u548c\u6cf0\uff08Ozempic\uff09\u3001\u8bfa\u548c\u76c8\uff08Wegovy\uff09\u548c\u7a46\u5cf0\u8fbe\uff08Mounjaro\uff09\u7b49\u836f\u7269\u6700\u521d\u662f\u4e3a\u6cbb\u7597\u7cd6\u5c3f\u75c5\u548c\u80a5\u80d6\u75c7\u800c\u5f00\u53d1\u7684\uff0c\u4f46\u5176\u76ca\u5904\u8fdc\u4e0d\u6b62\u4e8e\u51cf\u91cd\u3002\u5230 2025 \u5e74\uff0c\u76f8\u5173\u8bc1\u636e\u76f8\u5f53\u5145\u5206\uff1a\u8fd9\u4e9b\u836f\u7269\u5728\u591a\u4e2a\u8870\u8001\u7684\u6807\u5fd7\u6027\u7279\u5f81\u4e0a\u5747\u663e\u793a\u51fa\u6548\u679c\u3002<\/p>\n<p>\u4ec5\u5fc3\u8840\u7ba1\u4fdd\u62a4\u4f5c\u7528\u5c31\u5df2\u5341\u5206\u663e\u8457\u3002\u91cc\u7a0b\u7891\u5f0f\u7684\u8bd5\u9a8c\u8868\u660e\uff0cGLP-1 \u7c7b\u836f\u7269\u53ef\u5c06\u4e3b\u8981\u4e0d\u826f\u5fc3\u8840\u7ba1\u4e8b\u4ef6\u51cf\u5c11 13-26%\uff0c\u5176\u76ca\u5904\u751a\u81f3\u5ef6\u4f38\u81f3\u975e\u7cd6\u5c3f\u75c5\u4e2a\u4f53\u3002\u4e0d\u6b62\u4e8e\u6b64,\u8fd9\u4e9b\u836f\u7269\u80fd\u51cf\u8f7b\u6162\u6027\u708e\u75c7\u3001\u6539\u5584\u80be\u529f\u80fd\u3001\u9006\u8f6c\u8102\u80aa\u809d\uff0c\u5e76\u663e\u793a\u51fa\u65b0\u5174\u7684\u795e\u7ecf\u4fdd\u62a4\u7279\u6027\uff0c\u53ef\u80fd\u6709\u52a9\u4e8e\u89e3\u51b3\u8ba4\u77e5\u80fd\u529b\u4e0b\u964d\u95ee\u9898\u3002<\/p>\n<p>\u6700\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0cGLP-1 \u7c7b\u836f\u7269\u53ef\u80fd\u662f\u9996\u7c7b\u76f4\u63a5\u9776\u5411\u751f\u7269\u8870\u8001\u673a\u5236\u7684\u836f\u7269\u30022024-2025 \u5e74\u53d1\u8868\u7684\u7814\u7a76\u663e\u793a\uff0cSGLT2 \u6291\u5236\u5242\uff08\u4e00\u7c7b\u76f8\u5173\u836f\u7269\uff09\u53ef\u901a\u8fc7\u589e\u5f3a\u514d\u75ab\u76d1\u89c6\u6e05\u9664\u8870\u8001\u7684\u201c\u50f5\u5c38\u201d\u7ec6\u80de\uff0c\u5728\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53ef\u4fc3\u8fdb\u7aef\u7c92\u5ef6\u957f\uff0c\u5e76\u5728\u52a8\u7269\u6a21\u578b\u4e2d\u5c06\u5bff\u547d\u5ef6\u957f\u9ad8\u8fbe 14%\u3002\u4e00\u9879\u7814\u7a76\u8868\u660e\uff0c\u4ec5 26 \u5468\u540e\uff0c\u6052\u683c\u5217\u51c0\uff08Henagliflozin\uff09\u4f7f 90.5%\u7684\u53d7\u8bd5\u8005\u7aef\u7c92\u5ef6\u957f\uff0c\u800c\u5b89\u6170\u5242\u7ec4\u4e3a 65.6%\u3002<\/p>\n<p>\u5176\u5f71\u54cd\u53ef\u8c13\u6df1\u8fdc\u3002\u7814\u7a76\u663e\u793a\uff0cGLP-1 \u7c7b\u836f\u7269\u4f3c\u4e4e\u53ef\u4ee5\u91cd\u65b0\u6821\u51c6\u4ee3\u8c22\u5065\u5eb7\u548c\u5185\u810f\u8102\u80aa\u5206\u5e03\uff0c\u5728\u4fdd\u62a4\u5fc3\u8840\u7ba1\u548c\u80be\u529f\u80fd\u7684\u540c\u65f6\u51cf\u8f7b\u708e\u75c7\uff0c\u964d\u4f4e\u809d\u810f\u8102\u80aa\u548c\u7ea4\u7ef4\u5316\uff0c\u751a\u81f3\u53ef\u80fd\u589e\u5f3a\u8ba4\u77e5\u97e7\u6027\u3002\u8fd9\u4e9b\u5e76\u975e\u9644\u5e26\u76ca\u5904\uff0c\u800c\u662f\u8bc1\u636e\uff0c\u8868\u660e\u8c03\u8282\u57fa\u7840\u7684\u8425\u517b\u611f\u5e94\u901a\u8def\u53ef\u4ee5\u91cd\u5851\u8870\u8001\u672c\u8eab\u7684\u8f68\u8ff9\u3002<\/p>\n<p>\u793c\u6765\uff08Eli Lilly\uff09\u548c\u8bfa\u548c\u8bfa\u5fb7\uff08Novo Nordisk\uff09\u987a\u52bf\u800c\u4e3a\u3002,\u90fd\u660e\u786e\u5730\u4e3a\u5176 GLP-1 \u9879\u76ee\u91c7\u7528\u4e86\u201c\u957f\u5bff\u201d\u6846\u67b6\uff0c\u8fdc\u8fdc\u8d85\u51fa\u4e86\u7cd6\u5c3f\u75c5\u548c\u80a5\u80d6\u75c7\u7684\u8303\u7574\uff0c\u8fdb\u5165\u4e86\u5065\u5eb7\u5bff\u547d\u5ef6\u957f\u9886\u57df\u3002\u4fe1\u606f\u5f88\u660e\u786e\uff1a\u8870\u8001\u751f\u7269\u5b66\u5df2\u4ece\u8fb9\u7f18\u8d70\u5411\u4f01\u4e1a\u6218\u7565\u6838\u5fc3\u3002<\/p>\n<h3><strong>\u5927\u578b\u5236\u836f\u516c\u53f8\u5efa\u7acb\u8870\u8001\u7814\u7a76\u90e8\u95e8<\/strong><\/h3>\n<p>\u5236\u836f\u884c\u4e1a\u5bf9\u957f\u5bff\u7814\u7a76\u7684\u63a5\u7eb3\u8fdc\u4e0d\u6b62\u4e8e\u91cd\u65b0\u5229\u7528\u73b0\u6709\u836f\u7269\u3002\u8bfa\u534e\uff08Novartis\uff09\u6210\u7acb\u4e86\u5176\u8870\u8001\u4e0e\u518d\u751f\u533b\u5b66\u75be\u75c5\uff08Diseases of Aging and Regenerative Medicine \uff0cDARe\uff09\u90e8\u95e8\uff0c\u660e\u786e\u4e13\u6ce8\u4e8e\u4ece\u8870\u8001\u751f\u7269\u5b66\u4e2d\u53d1\u73b0\u65b0\u7684\u6cbb\u7597\u9776\u70b9\u3002\u8fd9\u4e0d\u662f\u4e00\u4e2a\u5c0f\u578b\u63a2\u7d22\u56e2\u961f\uff0c\u8fd9\u662f\u4e00\u4e2a\u7531\u91cd\u5927\u5408\u4f5c\u534f\u8bae\u652f\u6301\u7684\u6218\u7565\u627f\u8bfa\u3002<\/p>\n<p>2024 \u5e74 12 \u6708\uff0c\u8bfa\u534e\u5ba3\u5e03\u4e0e BioAge Labs \u8fbe\u6210\u4e00\u9879\u4ef7\u503c\u9ad8\u8fbe 5.5 \u4ebf\u7f8e\u5143\u7684\u5408\u4f5c\uff0c\u9884\u4ed8 2,000 \u4e07\u7f8e\u5143\u4ee5\u4f7f\u7528 BioAge \u7684\u4eba\u7c7b\u957f\u5bff\u6570\u636e\u96c6\uff0c\u805a\u7126\u8870\u8001\u4e0e\u8fd0\u52a8\u751f\u7269\u5b66\u4ea4\u53c9\u5904\u7684\u9776\u70b9\u53d1\u73b0\u3002\u8be5\u5408\u4f5c\u65e8\u5728\u8bc6\u522b\u4ecb\u5bfc\u8fd0\u52a8\u79ef\u6781\u6548\u5e94\u7684\u5206\u5b50\u56e0\u7d20\u2014\u2014\u5bfb\u627e\u836f\u7406\u5b66\u6377\u5f84\uff0c\u4ee5\u83b7\u5f97\u968f\u5e74\u9f84\u589e\u957f\u800c\u8870\u51cf\u7684\u8fd0\u52a8\u76ca\u5904\u3002<\/p>\n<p>BioAge \u7684\u5e73\u53f0\u4f53\u73b0\u4e86\u65b0\u8303\u5f0f\uff1a\u8fd9\u4e9b\u516c\u53f8\u4e0d\u662f\u4ece\u75be\u75c5\u51fa\u53d1\u53cd\u5411\u7814\u7a76\uff0c\u800c\u662f\u8bc6\u522b\u90a3\u4e9b\u8870\u8001\u8fc7\u7a0b\u5f02\u5e38\u5065\u5eb7\u7684\u4eba\u7fa4\uff0c\u7eb5\u5411\u6d4b\u91cf\u6570\u5343\u79cd\u751f\u7269\u5206\u5b50\uff0c\u5e76\u4f7f\u7528\u8ba1\u7b97\u5de5\u5177\u63d0\u53d6\u6f5c\u5728\u7684\u6cbb\u7597\u9776\u70b9\u3002\u5236\u836f\u516c\u53f8\u6b63\u5728\u5bc6\u5207\u5173\u6ce8\u8fd9\u7cbe\u51c6\u533b\u5b66\u4e0e\u8001\u5e74\u79d1\u5b66\u7684\u7ed3\u5408\u3002<\/p>\n<p>\u793c\u6765\u901a\u8fc7\u5176 ExploR&amp;D \u5408\u4f5c\u90e8\u95e8\u91c7\u53d6\u4e86\u7c7b\u4f3c\u7684\u65b9\u6cd5\uff0c\u4e0e BioAge \u5408\u4f5c\u5f00\u53d1\u9776\u5411\u4ee3\u8c22\u8870\u8001\u901a\u8def\u7684\u6cbb\u7597\u6027\u6297\u4f53\u3002\u8be5\u516c\u53f8\u8fd8\u5728\u8fdb\u884c\u8054\u5408\u8bd5\u9a8c\uff0c\u5c06\u5176\u91cd\u78c5 GLP-1 \u836f\u7269\u66ff\u897f\u5e15\u80bd\uff08Tirzepatide\uff09\uff08\u53c8\u540d Mounjaro\/Zepbound\uff09\u8054\u7528\uff0c\u4ee5\u5728\u51cf\u91cd\u8fc7\u7a0b\u4e2d\u7ef4\u6301\u808c\u8089\u91cf, \u8fd9\u5bf9\u8001\u5e74\u4f7f\u7528\u8005\u5c24\u4e3a\u5173\u952e\u3002<\/p>\n<h3><strong>\u4eba\u5de5\u667a\u80fd\u9a71\u52a8\u7684\u836f\u7269\u53d1\u73b0\u91cc\u7a0b\u7891<\/strong><\/h3>\n<p>\u5728\u201c\u65e7\u836f\u65b0\u7528\u201d\u4e4b\u5916\uff0c\u9762\u5411\u8870\u8001\u673a\u5236\u7684\u5168\u65b0\u5206\u5b50\u540c\u6837\u8fce\u6765\u5173\u952e\u9a8c\u8bc1\u30022024 \u5e74 9 \u6708\uff0c\u82f1\u77fd\u667a\u80fd\uff08Insilico Medicine\uff09\u5ba3\u5e03\u5176 ISM001-055\uff08\u73b0\u79f0\u4e3a Rentosertib\uff09\u53d6\u5f97\u4e86\u79ef\u6781\u7684 2a \u671f\u7ed3\u679c\uff0c\u8fd9\u662f\u4e00\u79cd\u5b8c\u5168\u4f7f\u7528\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u8bbe\u8ba1\u7684 TNIK \u6291\u5236\u5242\uff0c\u7528\u4e8e\u6cbb\u7597\u7279\u53d1\u6027\u80ba\u7ea4\u7ef4\u5316\u3002<\/p>\n<p>\u8bd5\u9a8c\u7ed3\u679c\u975e\u5e38\u7a81\u51fa\uff1a\u4ec5 12 \u5468\u540e\uff0c\u63a5\u53d7\u6700\u9ad8\u5242\u91cf\u6cbb\u7597\u7684\u60a3\u8005\u80ba\u529f\u80fd\u5e73\u5747\u6539\u5584\u4e86 98.4 mL\uff0c\u800c\u5b89\u6170\u5242\u7ec4\u5219\u4e0b\u964d\u4e86 62.3 mL\u3002\u66f4\u91cd\u8981\u7684\u662f\uff0c\u8be5\u836f\u7269\u9776\u5411 TNIK\uff08\u4e00\u79cd\u4e0e\u7ea4\u7ef4\u5316\u75be\u75c5\u548c\u8870\u8001\u8fc7\u7a0b\u6709\u5173\u7684\u6fc0\u9176\uff09\uff0c\u4ee3\u8868\u4e86\u4e00\u79cd\u901a\u8fc7\u8870\u8001\u751f\u7269\u5b66\u7684\u8ba1\u7b97\u5206\u6790\u786e\u5b9a\u7684\u5168\u65b0\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<p>\u82f1\u77fd\u667a\u80fd\u9996\u5e2d\u6267\u884c\u5b98 Alex Zhavoronkov \u8868\u793a\uff1a\u201c\u867d\u7136\u6211\u4eec\u9884\u8ba1\u8be5\u836f\u7269\u662f\u5b89\u5168\u7684\uff0c\u4f46\u6211\u4eec\u6ca1\u60f3\u5230\u5728\u5982\u6b64\u77ed\u7684\u7ed9\u836f\u671f\u540e\u4f1a\u770b\u5230\u5982\u6b64\u6e05\u6670\u7684\u5242\u91cf\u4f9d\u8d56\u6027\u7597\u6548\u4fe1\u53f7\u3002\u201d\u201c\u901a\u8fc7\u6211\u4eec\u65b0\u9896\u7684 TNIK \u6291\u5236\u5242\uff0c\u6211\u4eec\u8bd5\u56fe\u9488\u5bf9\u6211\u4eec\u8ba4\u4e3a\u662f\u7ea4\u7ef4\u5316\u75be\u75c5\u548c\u8870\u8001\u4e2d\u7684\u4e00\u4e2a\u5171\u540c\u673a\u5236\uff0c\u4ee5\u6700\u5927\u9650\u5ea6\u5730\u6269\u5c55\u9002\u5e94\u75c7\u201d\u3002<\/p>\n<p>\u8be5\u7814\u7a76\u4e8e 2025 \u5e74 6 \u6708\u53d1\u8868\u5728\u300a\u81ea\u7136\u00b7\u533b\u5b66\u300b\u4e0a\uff0c\u5de9\u56fa\u4e86\u5176\u79d1\u5b66\u5206\u91cf\u3002\u8fd9\u662f\u4e00\u4e2a\u5206\u6c34\u5cad\uff1a\u4e00\u79cd\u7531\u4eba\u5de5\u667a\u80fd\u53d1\u73b0\u3001\u9776\u5411\u8870\u8001\u673a\u5236\u7684\u836f\u7269\uff0c\u5728\u4ece\u9776\u70b9\u8bc6\u522b\u5230 2a \u671f\u7ed3\u679c\u8bfb\u51fa\u7684\u4e0d\u5230\u56db\u5e74\u65f6\u95f4\u91cc\uff0c\u5728\u4eba\u4f53\u4e2d\u8bc1\u660e\u4e86\u4e34\u5e8a\u7597\u6548\u3002\u4f20\u7edf\u7684\u836f\u7269\u5f00\u53d1\u65f6\u95f4\u7ebf\u88ab\u5927\u5e45\u538b\u7f29\uff0c\u800c\u9776\u70b9\u672c\u8eab\u4e5f\u6e90\u4e8e\u8870\u8001\u751f\u7269\u5b66\uff0c\u800c\u975e\u4ee5\u75be\u75c5\u4e3a\u4e2d\u5fc3\u7684\u7814\u7a76\u3002<\/p>\n<h3><strong>Senolytics\uff08\u6297\u8870\u8001\u836f\u7269\uff09\u8fdb\u5165\u4eba\u4f53\u6d4b\u8bd5<\/strong><\/h3>\n<p>\u7ec6\u80de\u8870\u8001\u2014\u2014\u5373\u5206\u6ccc\u708e\u75c7\u56e0\u5b50\u7684\u53d7\u635f\u201c\u50f5\u5c38\u201d\u7ec6\u80de\u7684\u7d2f\u79ef\u2014\u2014\u662f\u52a8\u7269\u6a21\u578b\u4e2d\u5f97\u5230\u6700\u4e25\u683c\u9a8c\u8bc1\u7684\u8870\u8001\u6807\u5fd7\u4e4b\u4e00\u3002\u5230 2025 \u5e74\uff0c\u7cbe\u51c6\u53bb\u8870\u8001\u5242(Senolytic)\u836f\u7269\u7684\u9996\u6b21\u4eba\u4f53\u8bd5\u9a8c\u5df2\u7ecf\u542f\u52a8\uff0c\u4f7f\u8fd9\u4e00\u9886\u57df\u4ece\u4ec5\u505c\u7559\u5728\u4e34\u5e8a\u524d\u7814\u7a76\u524d\u666f\u8fc8\u5411\u771f\u6b63\u7684\u4e34\u5e8a\u9636\u6bb5\u3002<\/p>\n<p>2025 \u5e74 6 \u6708\uff0cRubedo Life Sciences \u5728\u5176 RLS-1496 \u7684 1 \u671f\u8bd5\u9a8c\u4e2d\u4e3a\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u4f7f\u5176\u6210\u4e3a\u9996\u4e2a\u8fdb\u5165\u4eba\u4f53\u7814\u7a76\u7684 GPX4 \u8c03\u8282\u5242\u3002\u8be5\u836f\u7269\u901a\u8fc7\u4e00\u79cd\u590d\u6742\u7684\u673a\u5236\u8d77\u4f5c\u7528\uff1a\u5b83\u901a\u8fc7\u8c03\u8282\u94c1\u6b7b\u4ea1\uff08\u4e00\u79cd\u7531\u8102\u8d28\u8fc7\u6c27\u5316\u9a71\u52a8\u7684\u7ec6\u80de\u6b7b\u4ea1\u5f62\u5f0f\uff09\u9776\u5411\u75c5\u7406\u6027\u8870\u8001\u7ec6\u80de\u3002Rubedo \u7684\u65b9\u6cd5\u5e76\u975e\u65e0\u5dee\u522b\u6e05\u9664\u5730\u6e05\u9664\u6240\u6709\u8870\u8001\u7ec6\u80de\uff0c\u800c\u662f\u5229\u7528\u5355\u7ec6\u80de\u5206\u6790\u6765\u8bc6\u522b\u5e76\u4ec5\u6e05\u9664\u6709\u6bd2\u7684\u53d8\u4f53\u3002\u200b<\/p>\n<p>\u8bd5\u9a8c\u8bbe\u8ba1\u672c\u8eab\u5c31\u6807\u5fd7\u7740\u8be5\u9886\u57df\u7684\u6210\u719f\u3002Rubedo \u6ca1\u6709\u4ece\u5065\u5eb7\u5fd7\u613f\u8005\u5f00\u59cb\uff0c\u800c\u662f\u8fdb\u884c\u4e86\u4e00\u9879\u7bee\u5b50\u8bd5\u9a8c\uff0c\u5e73\u884c\u8bc4\u4ef7\u591a\u79cd\u76ae\u80a4\u75c5\u75c7\uff0c\u5305\u62ec\u94f6\u5c51\u75c5\u3001\u7279\u5e94\u6027\u76ae\u708e\u548c\u5149\u8001\u5316\u76ae\u80a4\uff0c\u4ece\u800c\u80fd\u591f\u65e9\u671f\u8bc4\u4f30\u5176\u5728\u708e\u75c7-\u8870\u8001\u8c31\u7cfb\u4e2d\u7684\u6cbb\u7597\u6f5c\u529b\u3002\u5982\u679c\u6210\u529f\uff0c\u8be5\u516c\u53f8\u8ba1\u5212\u5728 2026 \u5e74\u63a8\u8fdb\u5168\u8eab\u6027\u5236\u5242\uff0c\u9776\u5411\u80a5\u80d6\u3001\u75bc\u75db\u548c\u5176\u4ed6\u4e0e\u5e74\u9f84\u76f8\u5173\u7684\u75c5\u75c7\u3002<\/p>\n<p>\u4f5c\u4e3a\u6700\u65e9\u7684 Senolytics \u516c\u53f8\u4e4b\u4e00\uff0cUnity Biotechnology \u4e8e 2025 \u5e74 3 \u6708\u62a5\u544a\u4e86\u5176 UBX1325 \u5728\u6cbb\u7597\u7cd6\u5c3f\u75c5\u6027\u9ec4\u6591\u6c34\u80bf\u65b9\u9762\u7684 2b \u671f\u8bd5\u9a8c\u53d6\u5f97\u4e86\u4ee4\u4eba\u9f13\u821e\u7684\u7ed3\u679c\u3002\u867d\u7136\u5728\u4e00\u4e2a\u65f6\u95f4\u70b9\u4e0a\u4e3b\u8981\u7ec8\u70b9\u672a\u80fd\u8fbe\u5230\u7edf\u8ba1\u5b66\u663e\u8457\u6027\uff0c\u4f46\u5728 36 \u5468\u5185\uff0c\u8be5\u836f\u7269\u5728\u5341\u4e2a\u65f6\u95f4\u70b9\u4e2d\u7684\u4e5d\u4e2a\u65f6\u95f4\u70b9\u4e0a\u663e\u793a\u51fa\u8d85\u8fc7\u4e94\u4e2a\u5b57\u6bcd\u7684\u89c6\u529b\u589e\u76ca\uff0c\u5e76\u8fbe\u5230\u4e86\u4e0e\u6807\u51c6\u6297 VEGF \u7597\u6cd5\u76f8\u6bd4\u7684\u975e\u52a3\u6548\u6027\uff0c\u540c\u65f6\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u65e0\u708e\u75c7\u75c5\u4f8b\u3002<\/p>\n<p>\u8fd9\u4e9b\u7ed3\u679c\u4e4b\u6240\u4ee5\u91cd\u8981\uff0c\u662f\u56e0\u4e3a\u5b83\u4eec\u8868\u660e\uff0c\u5728\u7279\u5b9a\u7ec4\u7ec7\u5c40\u90e8\u7ed9\u836f\u65f6\uff0c\u53bb\u8870\u8001\u7b56\u7565\u5df2\u80fd\u5728\u4eba\u7fa4\u4e2d\u5e26\u6765\u53ef\u89c2\u7684\u4e34\u5e8a\u83b7\u76ca\uff1b\u4e0b\u4e00\u6b65\u7684\u5173\u952e\u5728\u4e8e\u5411\u66f4\u5e7f\u6cdb\u7684\u5e74\u9f84\u76f8\u5173\u75be\u75c5\u5f00\u5c55\u201c\u5168\u8eab\u7ed9\u836f\u201d\u63a2\u7d22<\/p>\n<h3><strong>\u8868\u89c2\u9057\u4f20\u91cd\u7f16\u7a0b\u65b9\u6cd5\u8d70\u5411\u4e34\u5e8a<\/strong><\/h3>\n<p>\u6216\u8bb8\u6700\u96c4\u5fc3\u52c3\u52c3\u7684\u957f\u5bff\u65b9\u6cd5\uff0c\u5373\u90e8\u5206\u8868\u89c2\u9057\u4f20\u91cd\u7f16\u7a0b\uff0c\u5df2\u8fc5\u901f\u5411\u4eba\u4f53\u8bd5\u9a8c\u8fc8\u8fdb\u3002\u8fd9\u4e2a\u6982\u5ff5\u5f88\u5de7\u5999\u4f46\u6280\u672f\u5b9e\u73b0\u4e0a\u5177\u6709\u6311\u6218\u6027\uff1a\u4f7f\u7528\u8f6c\u5f55\u56e0\u5b50\uff08\u901a\u5e38\u662f\u5c71\u4e2d\u56e0\u5b50\u7684\u53d8\u4f53\uff09\u6765\u91cd\u7f6e\u7ec6\u80de\u5e74\u9f84\uff0c\u800c\u4e0d\u4f1a\u8bf1\u5bfc\u591a\u80fd\u6027\u6216\u764c\u75c7\u98ce\u9669\u3002<\/p>\n<p>Life Biosciences \u5728 2025 \u5e74\u5e95\u5ba3\u5e03\uff0c\u5c06\u4e8e 2026 \u5e74\u7b2c\u4e00\u5b63\u5ea6\u542f\u52a8 ER-100 \u7528\u4e8e\u6cbb\u7597\u89c6\u795e\u7ecf\u75c5\u53d8\u7684\u9996\u6b21\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u3002\u8be5\u57fa\u56e0\u7597\u6cd5\u901a\u8fc7\u73bb\u7483\u4f53\u5185\u6ce8\u5c04\u9012\u9001\u4e09\u79cd\u8f6c\u5f55\u56e0\u5b50\uff08Oct-4\u3001Sox-2 \u548c Klf-4\uff09\uff0c\u5e76\u7ed3\u5408\u5168\u8eab\u6027\u591a\u897f\u73af\u7d20\u6765\u63a7\u5236\u8868\u8fbe\u65f6\u673a\u3002<\/p>\n<p>2025 \u5e74\u5728\u591a\u4e2a\u4f1a\u8bae\u4e0a\u5c55\u793a\u7684\u4e34\u5e8a\u524d\u6570\u636e\u663e\u793a\uff0cER-100 \u5728\u975e\u52a8\u8109\u708e\u6027\u524d\u90e8\u7f3a\u8840\u6027\u89c6\u795e\u7ecf\u75c5\u53d8\uff08nonarteritic anterior ischemic optic neuropathy\uff0cNAION\uff09\u7684\u975e\u4eba\u7075\u957f\u7c7b\u52a8\u7269\u6a21\u578b\u4e2d\u6062\u590d\u4e86\u89c6\u89c9\u529f\u80fd\uff0c\u6539\u5584\u4e86\u89c6\u7f51\u819c\u795e\u7ecf\u8282\u7ec6\u80de\u529f\u80fd\uff0c\u5e76\u6062\u590d\u4e86\u5bcc\u542b\u795e\u7ecf\u5143\u518d\u751f\u7684\u7532\u57fa\u5316\u6a21\u5f0f\u3002\u8be5\u516c\u53f8\u8fd8\u5728\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u4ee3\u8c22\u6027\u809d\u75c5\u7684 ER-300\uff0c\u6570\u636e\u663e\u793a\u5728\u5c0f\u9f20\u6a21\u578b\u4e2d\u809d\u9176\u548c\u7ea4\u7ef4\u5316\u8bc4\u5206\u6709\u663e\u8457\u6539\u5584\u3002<\/p>\n<p>\u7531 Coinbase \u9996\u5e2d\u6267\u884c\u5b98 Brian Armstrong \u652f\u6301\u3001\u7d2f\u8ba1\u83b7\u5f97 2.8 \u4ebf\u7f8e\u5143\u8d44\u91d1\u7684 NewLimit \u516c\u53f8\uff0c\u91c7\u53d6\u4e86\u4e00\u79cd\u7565\u6709\u4e0d\u540c\u7684\u65b9\u6cd5\uff0c\u4e13\u6ce8\u4e8e\u901a\u8fc7\u8868\u89c2\u9057\u4f20\u91cd\u7f16\u7a0b\u4ee5\u5b9e\u73b0\u809d\u810f\u548c\u514d\u75ab\u7cfb\u7edf\u7684\u5e74\u8f7b\u5316\u3002\u8be5\u516c\u53f8\u7b5b\u9009\u4e86\u8d85\u8fc7 3,000 \u79cd\u8f6c\u5f55\u56e0\u5b50\u7ec4\u5408\uff0c\u5e76\u786e\u5b9a\u4e86 20 \u591a\u7ec4\u80fd\u591f\u6062\u590d\u809d\u7ec6\u80de\u548c T \u7ec6\u80de\u5e74\u8f7b\u529f\u80fd\u7684\u7ec4\u5408\u3002\u5230 2025 \u5e74 12 \u6708\uff0cNewLimit \u62a5\u544a\u79f0\u5176\u201c\u63a5\u8fd1\u201d\u62e5\u6709\u53ef\u7528\u4e8e\u4e34\u5e8a\u7684\u8868\u89c2\u9057\u4f20\u91cd\u7f16\u7a0b\u7597\u6cd5\u3002<\/p>\n<p>Altos Labs \u662f\u7531 Jeff Bezos \u548c\u5176\u4ed6\u79d1\u6280\u540d\u4eba\u652f\u6301\u3001\u4ef7\u503c 30 \u4ebf\u7f8e\u5143\u7684\u7ec6\u80de\u518d\u751f\u516c\u53f8\uff0c\u8fd9\u5bb6\u516c\u53f8\u5728 2025 \u5e74\u4e2d\u671f\u4efb\u547d Joan Mannick \u535a\u58eb\u4e3a\u9996\u5e2d\u533b\u7597\u5b98\uff0c\u6807\u5fd7\u7740\u5176\u5411\u4e34\u5e8a\u5f00\u53d1\u7684\u8f6c\u53d8\u3002Mannick \u5728\u8bbe\u8ba1\u4ee5\u8870\u8001\u4e3a\u91cd\u70b9\u7684\u4e34\u5e8a\u8bd5\u9a8c\u65b9\u9762\u62e5\u6709\u4e30\u5bcc\u7ecf\u9a8c\uff0c\u5305\u62ec\u5979\u5728 resTORbio \u548c Tornado Therapeutics \u7684\u9886\u5bfc\u7ecf\u5386\uff0c\u8fd9\u8868\u660e Altos \u6b63\u51c6\u5907\u5c06\u5176\u90e8\u5206\u91cd\u7f16\u7a0b\u9879\u76ee\u63a8\u8fdb\u5230\u4eba\u4f53\u7814\u7a76\u9636\u6bb5\u3002<\/p>\n<h3><strong>\u653f\u5e9c\u652f\u6301\u52a0\u901f\u8be5\u9886\u57df\u53d1\u5c55<\/strong><\/h3>\n<p>\u8054\u90a6\u653f\u5e9c\u7684\u652f\u6301\u63d0\u4f9b\u4e86\u5173\u952e\u7684\u9a8c\u8bc1\u548c\u8d44\u6e90\u30022024 \u5e74 12 \u6708\uff0c\u7f8e\u56fd\u5065\u5eb7\u9ad8\u7ea7\u9879\u76ee\u5c40\uff08ARPA-H\uff09\u542f\u52a8\u4e86 PROSPR\uff08PROactive Solutions for Prolonging Resilience\uff0c\u5ef6\u957f\u97e7\u6027\u7684\u4e3b\u52a8\u89e3\u51b3\u65b9\u6848\uff09\u8ba1\u5212\uff0c\u5176\u660e\u786e\u76ee\u6807\u662f\u5c06\u7f8e\u56fd\u4eba\u7684\u5065\u5eb7\u5bff\u547d\u5ef6\u957f 20 \u5e74\u3002\u8be5\u8ba1\u5212\u65e8\u5728\u8bc6\u522b\u8870\u8001\u7684\u751f\u7406\u548c\u751f\u5316\u6807\u5fd7\u7269\uff0c\u5f00\u53d1\u8bc4\u4f30\u6280\u672f\uff0c\u5e76\u52a0\u901f\u65e8\u5728\u63d0\u9ad8\u5065\u5eb7\u5bff\u547d\u7684\u7597\u6cd5\u3002<\/p>\n<p>ARPA-H \u5411\u5df4\u514b\u7814\u7a76\u6240\uff08Buck Institute\uff09\u7684 PATH\uff08Personalized Analytics for Transforming Health\uff0c\u4e2a\u6027\u5316\u5206\u6790\u4ee5\u8f6c\u53d8\u5065\u5eb7\uff09\u9879\u76ee\u627f\u8bfa\u4e86\u9ad8\u8fbe 5,200 \u4e07\u7f8e\u5143\u7684\u8d44\u91d1\uff0c\u8be5\u9879\u76ee\u5c06\u62db\u52df\u4e00\u6279 50 \u5c81\u4ee5\u4e0a\u7684\u5065\u5eb7\u4e2a\u4f53\uff0c\u5e76\u4f7f\u7528\u53ef\u7a7f\u6234\u8bbe\u5907\u548c\u9ad8\u7ea7\u5206\u6790\u6280\u672f\u5bf9\u5176\u8fdb\u884c\u8ddf\u8e2a\uff0c\u4ee5\u5728\u6162\u6027\u75c5\u663e\u73b0\u4e4b\u524d\u8fdb\u884c\u9884\u6d4b\u548c\u9884\u9632\u3002\u5176\u7ecf\u6d4e\u7406\u7531\u4ee4\u4eba\u4fe1\u670d\uff1a\u82e5\u8ba9 10%\u7684\u8001\u9f84\u4eba\u7fa4\u5c06\u5065\u5eb7\u5bff\u547d\u4ec5\u5ef6\u957f\u4e00\u5e74\uff0c\u6bcf\u5e74\u5c06\u51cf\u5c11 290 \u4ebf\u7f8e\u5143\u7684\u798f\u5229\u8ba1\u5212\u6210\u672c\uff0c\u5e76\u4e3a\u7ecf\u6d4e\u589e\u52a0 800 \u4ebf\u7f8e\u5143\u3002<\/p>\n<p>\u6b63\u5982 ARPA-H \u4e3b\u4efb Renee Wegrzyn \u535a\u58eb\u6240\u6307\u51fa\u7684\uff1a\u201c\u7814\u7a76\u4eba\u5458\u548c\u79d1\u5b66\u5bb6\u6b63\u5728\u5bfb\u627e\u65b0\u65b9\u6cd5\u6765\u68c0\u6d4b\u548c\u5e72\u9884\u5927\u91cf\u975e\u75be\u75c5\u6027\u7684\u8870\u8001\u8d1f\u9762\u540e\u679c\uff0c\u5982\u8bb0\u5fc6\u529b\u3001\u542c\u529b\u548c\u808c\u8089\u529b\u91cf\u7684\u529f\u80fd\u6027\u4e0b\u964d\u201d\u3002\u5bf9\u201c\u53d1\u75c5\u524d\u529f\u80fd\u8870\u9000\u201d\u4f5c\u4e3a\u5408\u6cd5\u6cbb\u7597\u9776\u70b9\u7684\u8ba4\u53ef\uff0c\u6807\u5fd7\u7740\u76d1\u7ba1\u7406\u5ff5\u7684\u91cd\u8981\u6f14\u8fdb\u3002<\/p>\n<h3><strong>\u751f\u7269\u6807\u5fd7\u7269\u548c\u76d1\u7ba1\u7a81\u7834<\/strong><\/h3>\n<p>\u6216\u8bb8\uff0c\u4fc3\u6210\u957f\u5bff\u7597\u6cd5\u6700\u5173\u952e\u7684\u53d1\u5c55\u662f\u8870\u8001\u751f\u7269\u6807\u5fd7\u7269\u65b9\u9762\u7684\u76d1\u7ba1\u8fdb\u5c55\u3002\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08Food and Drug Administration\uff0cFDA\uff09\u548c\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\uff08European Medicines Agency\uff0cEMA\uff09\u7531\u4f20\u611f\u5668\u83b7\u53d6\u7684\u6570\u636e\u6307\u6807\u4f5c\u4e3a\u4e34\u5e8a\u7ec8\u70b9\uff0c\u5305\u62ec\u6b65\u901f\u3001\u5fc3\u7387\u53d8\u5f02\u6027\u548c\u7761\u7720\u6a21\u5f0f\u3002\u66f4\u91cd\u8981\u7684\u662f\uff0c2024-2025 \u5e74\u7684\u5021\u5bfc\u52aa\u529b\u63a8\u52a8\u5efa\u7acb\u4e00\u4e2a\u5168\u9762\u7684\u6846\u67b6\uff0c\u4ee5\u9a8c\u8bc1\u751f\u7269\u8870\u8001\u6807\u5fd7\u7269\u4f5c\u4e3a\u66ff\u4ee3\u7ec8\u70b9\u3002<\/p>\n<p>\u95ee\u9898\u4e00\u76f4\u5728\u4e8e\u65f6\u95f4\u5c3a\u5ea6\uff1a\u8bc1\u660e\u4e00\u79cd\u836f\u7269\u80fd\u5ef6\u957f\u5065\u5eb7\u5bff\u547d\u9700\u8981\u6570\u5341\u5e74\u7684\u968f\u8bbf\uff0c\u8fd9\u4f7f\u5f97\u5f00\u53d1\u5728\u7ecf\u6d4e\u4e0a\u4e0d\u53ef\u884c\u3002\u4f46\u5982\u679c\u7ecf\u8fc7\u9a8c\u8bc1\u7684\u751f\u7269\u6807\u5fd7\u7269\u80fd\u591f\u9884\u6d4b\u957f\u671f\u7ed3\u679c\uff0c\u8bd5\u9a8c\u4fbf\u53ef\u5728\u6570\u5e74\u800c\u975e\u6570\u5341\u5e74\u5185\u5b8c\u6210\u3002\u4e00\u4efd\u653f\u7b56\u7b80\u62a5\u8bba\u8ff0\u79f0\uff1a\u201c\u6b63\u5982\u53d1\u73b0\u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\uff08LDL\uff09\u4f5c\u4e3a\u5fc3\u810f\u5065\u5eb7\u7684\u66ff\u4ee3\u6807\u5fd7\u7269\u5bf9\u4e8e\u4ed6\u6c40\u7c7b\u836f\u7269\u7684\u6d4b\u8bd5\u548c\u5f00\u53d1\u81f3\u5173\u91cd\u8981\u4e00\u6837\uff0c\u53d1\u73b0\u4e34\u5e8a\u7ea7\u522b\u7684\u751f\u7269\u6807\u5fd7\u7269\u53ef\u80fd\u4f1a\u5f00\u542f\u65e8\u5728\u9776\u5411\u9a71\u52a8\u4eba\u7c7b\u8870\u8001\u673a\u5236\u7684\u65b0\u7597\u6cd5\u201d\u3002<\/p>\n<p>\u63a5\u53d7\u8870\u8001\u751f\u7269\u6807\u5fd7\u7269\u4f5c\u4e3a\u7ec8\u70b9\u5df2\u7ecf\u5f00\u59cb\u5f71\u54cd\u8bd5\u9a8c\u8bbe\u8ba1\u3002BioAge \u7684\u80a5\u80d6\u8bd5\u9a8c\u5305\u542b\u4e86\u751f\u7269\u5b66\u5e74\u9f84\u548c\u708e\u75c7\u7684\u63a2\u7d22\u6027\u6d4b\u91cf\u6307\u6807; Life Biosciences \u7684\u8868\u89c2\u9057\u4f20\u91cd\u7f16\u7a0b\u7814\u7a76\u5728\u8ddf\u8e2a\u75be\u75c5\u7279\u5f02\u6027\u7ed3\u679c\u7684\u540c\u65f6\uff0c\u4e5f\u8ddf\u8e2a\u7532\u57fa\u5316\u5e74\u9f84\u3002\u5404\u516c\u53f8\u6b63\u5728\u6301\u7eed\u7d2f\u79ef\u8bc1\u636e\uff0c\u671f\u671b\u672a\u6765\u80fd\u4ee5\u201c\u8870\u8001\/\u5065\u5eb7\u5bff\u547d\u5ef6\u957f\u201d\u4f5c\u4e3a\u76f4\u63a5\u9002\u5e94\u75c7\u83b7\u6279\uff0c\u800c\u4e0d\u518d\u53d7\u9650\u4e8e\u75be\u75c5\u7279\u5f02\u7ec8\u70b9\u3002<\/p>\n<h3><strong>\u8d44\u672c\u5e02\u573a\u5411\u957f\u5bff\u9886\u57df\u5f00\u653e<\/strong><\/h3>\n<p>2024-2025 \u5e74\u9996\u6b21\u516c\u5f00\u52df\u80a1\uff08IPO\uff09\u5e02\u573a\u7684\u56de\u6696\u4e3a\u957f\u5bff\u751f\u7269\u6280\u672f\u516c\u53f8\u63d0\u4f9b\u4e86\u5173\u952e\u7684\u8d44\u91d1\u6d41\u52a8\u6027\u3002BioAge Labs \u4e8e 2024 \u5e74 9 \u6708\u4e0a\u5e02\uff0c\u4ee5\u6bcf\u80a1 18 \u7f8e\u5143\u7684\u4f30\u503c\u7b79\u96c6\u4e86 1.98 \u4ebf\u7f8e\u5143\uff0c\u4f7f\u516c\u53f8\u5e02\u503c\u8fbe\u5230 6.06 \u4ebf\u7f8e\u5143\u3002\u6b64\u6b21\u53d1\u884c\u7531\u9ad8\u76db\uff08Goldman Sachs\uff09\u3001\u6469\u6839\u58eb\u4e39\u5229\uff08Morgan Stanley\uff09\u3001\u6770\u5bcc\u745e\uff08Jefferies\uff09\u548c\u82b1\u65d7\u96c6\u56e2\uff08Citigroup\uff09\u7275\u5934\u2014\u2014\u663e\u793a\u8fd9\u4e9b\u5927\u578b\u91d1\u878d\u673a\u6784\u90fd\u5728\u62bc\u6ce8\u8870\u8001\u751f\u7269\u5b66\u3002<\/p>\n<p>BioAge \u7684 IPO \u4ec5\u5728\u5176 1.7 \u4ebf\u7f8e\u5143\u7684 D \u8f6e\u878d\u8d44\u4e24\u4e2a\u6708\u540e\u8fdb\u884c\uff0c\u8868\u660e\u5c3d\u7ba1\u8be5\u516c\u53f8\u5728 2024 \u5e74 12 \u6708\u56e0\u809d\u9176\u5347\u9ad8\u800c\u51b3\u5b9a\u505c\u6b62\u5176 Azelaprag \u7684 2 \u671f\u80a5\u80d6\u8bd5\u9a8c\uff0c\u6295\u8d44\u8005\u5174\u8da3\u4ecd\u672a\u51cf\u9000\u3002\u516c\u53f8\u5e76\u672a\u56e0\u6b64\u5d29\u6e83\uff0c\u800c\u662f\u8f6c\u5411\u4e86\u4e0b\u4e00\u4ee3 APJ \u6fc0\u52a8\u5242\u548c NLRP3 \u708e\u75c7\u5c0f\u4f53\u6291\u5236\u5242\uff0c\u5e76\u501f\u52a9\u4e0e\u5236\u836f\u516c\u53f8\u7684\u5408\u4f5c\u5173\u7cfb\u6765\u7ef4\u6301\u53d1\u5c55\u52bf\u5934\u3002<\/p>\n<p>Jupiter Neurosciences \u548c Loyal\uff08\u4e13\u6ce8\u4e8e\u5ef6\u957f\u72ac\u7c7b\u5bff\u547d\uff09\u4e5f\u5728 2024 \u5e74\u5b8c\u6210\u4e86 IPO\uff0c\u800c\u50cf Rubedo Life Sciences \u8fd9\u6837\u7684\u516c\u53f8\u5219\u5b8c\u6210\u4e86\u91cd\u8981\u7684\u540e\u671f\u79c1\u52df\u878d\u8d44\u3002\u6b63\u5982\u4e00\u4f4d\u5206\u6790\u5e08\u6307\u51fa\u7684\uff1a\u201cIPO \u6b63\u5728\u590d\u82cf\uff0c\u957f\u5bff\u8d5b\u9053\u6216\u5c06\u8fce\u6765\u66f4\u591a\u4e0a\u5e02\u6848\u4f8b\u3002\u201d<\/p>\n<h3><strong>\u8870\u8001\u7684\u6807\u5fd7\u6027\u7279\u5f81\u6846\u67b6\u63d0\u4f9b\u4e86\u8def\u7ebf\u56fe<\/strong><\/h3>\n<p>\u4e0a\u8ff0\u8fdb\u5c55\u5efa\u7acb\u5728\u575a\u5b9e\u7684\u79d1\u5b66\u6839\u57fa\u4e4b\u4e0a\u30022013 \u5e74\u53d1\u8868\u7684\u8bba\u6587\u63d0\u51fa\u7684\u8870\u8001\u4e5d\u5927\u6807\u5fd7\u6846\u67b6(\u57fa\u56e0\u7ec4\u4e0d\u7a33\u5b9a\u6027\u3001\u7aef\u7c92\u635f\u8017\u3001\u8868\u89c2\u9057\u4f20\u5b66\u6539\u53d8\u3001\u86cb\u767d\u8d28\u7a33\u6001\u4e27\u5931\u3001\u8425\u517b\u611f\u5e94\u5931\u8c03\u3001\u7ebf\u7c92\u4f53\u529f\u80fd\u969c\u788d\u3001\u7ec6\u80de\u8870\u8001\u3001\u5e72\u7ec6\u80de\u8017\u7aed\u548c\u7ec6\u80de\u95f4\u901a\u8baf\u5f02\u5e38)\uff0c\uff0c\u5728 2023 \u5e74\u66f4\u65b0\u4e3a\u5341\u4e8c\u4e2a\u6807\u5fd7\u6027\u7279\u5f81\uff0c\u65b0\u589e\u4e86\u6162\u6027\u708e\u75c7\u3001\u5de8\u81ea\u566c\u529f\u80fd\u969c\u788d\u548c\u751f\u6001\u5931\u8c03\u3002<\/p>\n<p>\u8be5\u6846\u67b6\u4e3a\u65b0\u836f\u7814\u53d1\u63d0\u4f9b\u6e05\u6670\u201c\u9776\u70b9\u5730\u56fe\u201d\u3002\u6bcf\u4e2a\u6807\u5fd7\u6027\u7279\u5f81\u90fd\u4ee3\u8868\u4e00\u4e2a\u6f5c\u5728\u7684\u6cbb\u7597\u9776\u70b9\uff0c\u80fd\u591f\u201c\u4e00\u5242\u591a\u9776\u201d\u7684\u5e72\u9884\u5f80\u5f80\u7597\u6548\u66f4\u4f73\u3002GLP-1 \u7c7b\u836f\u7269\u8c03\u8282\u8425\u517b\u611f\u5e94\uff0c\u51cf\u8f7b\u708e\u75c7\uff0c\u5e76\u53ef\u80fd\u589e\u5f3a\u81ea\u566c; Senolytics \u6e05\u9664\u8870\u8001\u7ec6\u80de\u3002\u8868\u89c2\u9057\u4f20\u91cd\u7f16\u7a0b\u89e3\u51b3\u8868\u89c2\u9057\u4f20\u5b66\u6539\u53d8\uff0c\u5e76\u53ef\u80fd\u91cd\u7f6e\u591a\u4e2a\u8870\u8001\u8fc7\u7a0b; NAD+\u589e\u5f3a\u5242\u9776\u5411\u7ebf\u7c92\u4f53\u529f\u80fd\u969c\u788d\u548c\u86cb\u767d\u8d28\u7a33\u6001\u3002<\/p>\n<p>\u8870\u8001\u6807\u5fd7\u6027\u7279\u5f81\u7684\u76f8\u4e92\u5173\u8054\u6027\u610f\u5473\u7740\u5355\u4e00\u5e72\u9884\u53ef\u4ee5\u5728\u591a\u4e2a\u7cfb\u7edf\u4e2d\u4ea7\u751f\u7ea7\u8054\u6548\u76ca\u2014\u2014\u8fd9\u6b63\u662f GLP-1 \u7c7b\u836f\u7269\u5df2\u7ecf\u5c55\u73b0\u7684\u6548\u679c\uff0c\u4e5f\u6b63\u662f\u5438\u5f15\u5236\u836f\u516c\u53f8\u9ad8\u5ea6\u5173\u6ce8\u7684\u539f\u56e0\u3002<\/p>\n<h3><strong>\u524d\u8def\u6f2b\u6f2b\uff1a\u4ece\u7092\u4f5c\u5230\u533b\u7597\u4fdd\u5065<\/strong><\/h3>\n<p>\u524d\u8def\u5e76\u975e\u5766\u9014\uff1a\u5927\u591a\u6570\u7597\u6cd5\u4ecd\u5904\u4e8e\u65e9\u671f\u4e34\u5e8a\u5f00\u53d1\u9636\u6bb5\uff0c\u5728\u83b7\u5f97\u76d1\u7ba1\u6279\u51c6\u524d\u5c1a\u9700\u65f6\u65e5\u3002FDA \u7f3a\u4e4f\u201c\u8870\u8001\u201d\u9002\u5e94\u75c7\u610f\u5473\u7740\u516c\u53f8\u5fc5\u987b\u4ee5\u7279\u5b9a\u75be\u75c5\u4f5c\u4e3a\u4e3b\u8981\u7ec8\u70b9,\u5728\u666e\u904d\u5065\u5eb7\u4eba\u7fa4\u4e2d\u957f\u671f\u4f7f\u7528\u7684\u5b89\u5168\u6027\u9a8c\u8bc1\u4ea6\u9700\u8981\u5e7f\u6cdb\u9a8c\u8bc1\u3002\u884c\u4e1a\u5fc5\u987b\u5728\u5efa\u7acb\u8bc1\u636e\u57fa\u7840\u7684\u540c\u65f6\u907f\u514d\u8fc7\u5ea6\u627f\u8bfa\u3002<\/p>\n<p>\u5c3d\u7ba1\u6311\u6218\u72b9\u5b58,\u4f46\u52bf\u5934\u662f\u4e0d\u53ef\u5426\u8ba4\u7684\u3002\u6709\u4e13\u5bb6\u5728 2025 \u5e74\u603b\u7ed3\u79f0\uff1a\u201c\u957f\u5bff\u751f\u7269\u6280\u672f\u5728\u5927\u578b\u5236\u836f\u516c\u53f8\u5185\u90e8\u4e3b\u6d41\u5316\u7684\u901f\u5ea6\u8d85\u51fa\u4e86\u6211\u7684\u9884\u671f\uff0c\u8fd9\u5728\u5f88\u5927\u7a0b\u5ea6\u4e0a\u662f\u56e0\u4e3a GLP-1 \u65f6\u4ee3\u8ba9\u4eba\u4eec\u6e05\u695a\u5730\u770b\u5230\uff0c\u65b0\u9648\u4ee3\u8c22\u3001\u708e\u75c7\u548c\u8870\u8001\u751f\u7269\u5b66\u662f\u7d27\u5bc6\u76f8\u8fde\u7684\u3002\u201d\u53e6\u4e00\u4f4d\u6307\u51fa\uff1a\u201c\u4ee4\u4eba\u6b23\u559c\u7684\u662f\uff0c\u5927\u578b\u5236\u836f\u516c\u53f8\u548c\u653f\u5e9c\u5982\u6b64\u8fc5\u901f\u5730\u5c06\u957f\u5bff\u751f\u7269\u5b66\u89c6\u4e3a\u6838\u5fc3\u7814\u53d1\u6218\u7565\u3002\u201d<\/p>\n<p>2025 \u5e74\uff0c\u591a\u4e2a\u8870\u8001\u751f\u7269\u5b66\u9879\u76ee\u8fdb\u5165\u4e86\u4e2d\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ece\u65e9\u671f\u7684\u5b89\u5168\u6027\u7814\u7a76\u8f6c\u5411\u8bc4\u4f30\u529f\u80fd\u6027\u7ed3\u679c\u7684\u8bd5\u9a8c\u3002\u957f\u5bff\u521d\u521b\u516c\u53f8\u4e0e\u5927\u578b\u5236\u836f\u516c\u53f8\u4e4b\u95f4\u7684\u6218\u7565\u5408\u4f5c\u8868\u660e\uff0c\u5065\u5eb7\u5bff\u547d\u5df2\u4ece\u8fb9\u7f18\u7814\u53d1\u8d70\u5411\u4e3b\u6d41\u3002\u800c\u4e14\u81f3\u5173\u91cd\u8981\u7684\u662f\uff0c\u8fd9\u4e9b\u5408\u4f5c\u4e4b\u6240\u4ee5\u53d1\u751f\uff0c\u662f\u56e0\u4e3a\u516c\u53f8\u56f4\u7ed5\u8870\u8001\u751f\u7269\u5b66\u6765\u6784\u5efa\u5176\u5de5\u4f5c\uff0c\u800c\u4e0d\u662f\u65e0\u89c6\u5b83\u3002<\/p>\n<p>\u5f53\u4e0b, \u79d1\u5b66\u9a8c\u8bc1\uff08GLP-1 \u7684\u591a\u7cfb\u7edf\u76ca\u5904\u3001\u4eba\u5de5\u667a\u80fd\u53d1\u73b0\u7684\u836f\u7269\u8bc1\u660e\u7597\u6548\u3001Senolytics \u8fdb\u5165\u4eba\u4f53\u8bd5\u9a8c\uff09\u3001\u5546\u4e1a\u52a8\u529b\uff08\u4e13\u6ce8\u4e8e\u8870\u8001\u7684\u5236\u836f\u90e8\u95e8\u3001\u91cd\u5927\u5408\u4f5c\u3001\u6210\u529f\u7684 IPO\uff09\u3001\u76d1\u7ba1\u6f14\u8fdb\uff08\u751f\u7269\u6807\u5fd7\u7269\u88ab\u63a5\u53d7\u3001ARPA-H \u9879\u76ee\uff09\u548c\u7ecf\u6d4e\u538b\u529b\uff08\u8001\u9f84\u5316\u4eba\u53e3\u7684\u533b\u7597\u6210\u672c\uff09\u6b63\u52a0\u901f\u6c47\u805a\uff0c\u4e3a\u957f\u5bff\u7597\u6cd5\u4ece\u7814\u7a76\u597d\u5947\u5fc3\u5411\u4e34\u5e8a\u73b0\u5b9e\u7684\u8f6c\u53d8\u521b\u9020\u4e86\u6761\u4ef6\u3002<\/p>\n<p>\u672a\u6765\u4e94\u5e74\u5c06\u51b3\u5b9a\u8870\u8001\u751f\u7269\u5b66\u80fd\u5426\u5b9e\u73b0\u5176\u4f5c\u4e3a\u65b0\u6cbb\u7597\u8303\u5f0f\u7684\u627f\u8bfa\u3002\u4f46\u81ea 2024 \u5e74\u4ee5\u6765\u5960\u5b9a\u7684\u57fa\u7840\u8868\u660e\uff0c\u6211\u4eec\u6b63\u5728\u89c1\u8bc1\u7684\u4e0d\u4ec5\u4ec5\u662f\u53e6\u4e00\u4e2a\u751f\u7269\u6280\u672f\u8d8b\u52bf\uff0c\u800c\u662f\u533b\u5b66\u5bf9\u5f85\u5065\u5eb7\u3001\u75be\u75c5\u548c\u4eba\u7c7b\u5bff\u547d\u672c\u8eab\u65b9\u5f0f\u7684\u6839\u672c\u6027\u91cd\u65b0\u5b9a\u4f4d\u3002<\/p>\n<p>\u5982\u4eca\u7684\u95ee\u9898\u4e0d\u518d\u662f\u957f\u5bff\u7814\u7a76\u662f\u5426\u4f1a\u6210\u4e3a\u751f\u7269\u5236\u836f\u7684\u7126\u70b9\uff0c\u800c\u5728\u4e8e\u54ea\u4e9b\u8def\u5f84\u5c06\u9996\u5148\u60e0\u53ca\u60a3\u8005\uff0c\u4ee5\u53ca\u8be5\u9886\u57df\u80fd\u4ee5\u591a\u5feb\u7684\u901f\u5ea6\u5151\u73b0\u90a3\u4e9b\u5df2\u5438\u7eb3\u5168\u884c\u4e1a\u5173\u6ce8\u4e0e\u8d44\u672c\u7684\u5b8f\u4f1f\u84dd\u56fe \u3002<\/p>\n<p><em>\u4e86\u89e3\u66f4\u591a\u5173\u4e8e Cortellis \u4ea4\u6613\u60c5\u62a5\u6570\u636e\u5e93\u5982\u4f55\u5e2e\u52a9\u5236\u836f\u548c\u751f\u7269\u6280\u672f\u516c\u53f8\u4e86\u89e3\u4ea4\u6613\u683c\u5c40\u7684\u4fe1\u606f\uff1a<\/em><a href=\"https:\/\/clarivate.com.cn\/life-sciences-healthcare\/portfolio-strategy\/partnering-dealmaking\/cortellis-deals-intelligence-analytics\/\"><em>Cortellis\u5236\u836f\u4ea4\u6613\u60c5\u62a5\u4e0e\u5206\u6790 | \u79d1\u777f\u552f\u5b89<\/em><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u957f\u5bff\u7814\u7a76\u66fe\u88ab\u8ba4\u4e3a\u662f\u672a\u6765\u4e3b\u4e49\u8005\u548c\u8fb9\u7f18\u79d1\u5b66\u5bb6\u7684\u9886\u57df\uff0c\u73b0\u5df2\u8fc5\u901f\u6210\u4e3a\u836f\u7269\u5f00\u53d1\u4e2d\u6700\u5f15\u4eba\u6ce8\u76ee\u7684\u524d\u6cbf\u4e4b\u4e00\u3002\u8fd9\u4e00\u8f6c\u53d8\u5e76\u975e\u4e00\u8e74\u800c\u5c31\uff0c\u81ea 2024 \u5e74\u4ee5\u6765\uff0c\u79d1\u5b66\u7a81\u7834\u3001\u76d1\u7ba1\u6f14\u53d8\u548c\u524d\u6240\u672a\u6709\u7684\u5546\u4e1a\u5229\u76ca\u5171\u540c\u63a8\u52a8\u8870\u8001\u751f\u7269\u5b66\u4ece\u5b66\u672f\u5174\u8da3\u8d70\u5411\u4e86\u4f01\u4e1a\u6218\u7565\u3002<\/p>\n","protected":false},"author":7,"featured_media":435963,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[3,43],"tags":[47,54,73,65,56,78],"class_list":["post-435962","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-sciences-healthcare","category-biopharma","tag-ai-machine-learning","tag-glp-1","tag-clinical-trials","tag-trade","tag-pharmaceutical-regulations","tag-78"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-03 08:17:49","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/435962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=435962"}],"version-history":[{"count":7,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/435962\/revisions"}],"predecessor-version":[{"id":435983,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/435962\/revisions\/435983"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/435963"}],"wp:attachment":[{"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=435962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=435962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.clarivate.com.cn\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=435962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}